Articles written specifically for the GLP or the articles that are reposted from other sources (sometimes in modified form) with permission list the source as Genetic Literacy Project. Excerpted articles list the original media outlet as the source. Excerpts are posted under guidelines for Fair Use and Creative Commons for educational nonprofits (501c3). The GLP’s Fair Use policy for posting excerpts and using images is explained here.
If you've received a COVID vaccine, how worried should you be about catching the Delta variant?

If you’ve received a COVID vaccine, how worried should you be about catching the Delta variant?

STAT | 
[Y]ou may have heard about Olympic athletes who are fully vaccinated getting positive Covid tests or people in Provincetown, Mass., ...
In an unprecedented move hoping to quell criticism, FDA releases documents detailing messy internal debate over Biogen's dementia drug Aduhelm

In an unprecedented move hoping to quell criticism, FDA releases documents detailing messy internal debate over Biogen’s dementia drug Aduhelm

STAT | 
[A] series of documents [were released June 22] by the FDA to explain its decision to use a truncated pathway, ...
remdesivir image x

Gilead’s remdesivir offers little benefit for coronavirus patients in early trial

STAT | 
The antiviral medicine remdesivir from Gilead Sciences failed to speed the improvement of patients with Covid-19 or prevent them from ...
sickle cell crispr x custom d cc c c d c e ad df e s c

CRISPR therapy demonstrates ‘real curative potential’ for sickle cell disease, beta thalassemia

STAT | 
The first two patients to receive a CRISPR-based treatment for the inherited blood disorders sickle cell disease and beta thalassemia ...
maxresdefault

Patient’s ‘serious’ kidney injury halts gene therapy trial for Duchenne muscular dystrophy

STAT | 
The Food and Drug Administration has halted a clinical trial involving a Duchenne muscular dystrophy gene therapy from Solid Biosciences ...
wnmktkpturbxy iowjkytblndu n exmjlknzhjnwnmnjawmtdjzmvimi qcgeslqmaom hcm d jmfzqmgzqhc

Animal safety concerns prompt FDA to halt study testing Zolgensma gene therapy for spinal muscular atrophy

STAT | 
The Food and Drug Administration has halted a clinical trial of Novartis’ Zolgensma gene therapy due to a safety concern ...
josiah zayner biohacker portrait

Podcast: Talking CRISPR with controversial biohacker Josiah Zayner

STAT | 
Is biohacking a crime? Who came up with the latest CRISPR trick? And did Rage Against the Machine sell out? ...
jruhu tlem hcqkrisrsith e xn padcwad dzro

Biohacker Josiah Zayner meets with California regulators investigating him: ‘It was surreal’

STAT | 
A few weeks ago, the prominent biohacker Josiah Zayner took to Instagram to break some news: He had received a ...
3-31-2019 thals patient

Gene therapy for beta-thalassemia blood disorder one step closer to European approval

STAT | 
The first gene therapy to treat a rare blood disorder is one step closer to approval [March 29] following a ...
3-21-2019 vera achana baby c d e ee d cd da ea

‘Game-changing’ drug first ever postpartum depression medication approved by FDA

STAT | 
The Food and Drug Administration on [March 19] approved brexanolone, the first drug specifically targeted to treat postpartum depression — ...
alzheimers disease

Promising Alzheimer’s drug trial halted

STAT | 
Alzheimer’s disease has beaten back another effort to tame it. Biogen and its Japanese pharma partner Eisai said [March 21] ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists